Arvinas (ARVN) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

ARVN is expected to report earnings to rise 101.00% to -98 cents per share on November 05

Q3'24

Est.

$-0.98

Q2'24

Beat

by $0.59

Q1'24

Beat

by $0.43

Q4'23

Missed

by $1.34

Q3'23

Beat

by $0.40

The last earnings report on July 30 showed earnings per share of -49 cents, beating the estimate of -108 cents. With 507.84K shares outstanding, the current market capitalization sits at 1.70B.

View a ticker or compare two or three

Compare

ARVN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ARVN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ARVN (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of therapies to degrade disease-causing proteins

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

395 Winchester Avenue

Phone

+1 203 535-1456

Employees

445

Web

https://www.arvinas.com